Traditional Chinese medicine composition for treating chronic nephritis proteinuria and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating chronic nephritis proteinuria, and the traditional Chinese medicine composition is mainly prepared by the following active pharmaceutical ingredients in parts by weight: 20-50 parts of raw membranous milkvetch root, 15-30 parts of pilose Asiabell root, 15-30 parts of Chinese peashrub root, 15-30 parts of raw coix seedroot, 18-30 parts of fructus forsythiae, 12-30 parts of honeysuckle flower, 18-30 parts of heartleaf houttuynia herb, 15-30 parts of spreading hedyotis herb, 9-20 parts of Szechuan lovage rhizome, 9-20 parts of tree peony bark, 15-30 parts of motherwort herb, 15-30 parts of Indian buead, 15-30 parts of corn silk and 15-30 parts of winged euonymus twig. In addition, the invention further disclosesa preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition can combine tonification with purgation, perform warming and cooling simultaneously,effectively eliminate the proteinuria and other pathological indicators of kidneys, delay and even block the progress of chronic nephritis and realize the significant protection effect for the kidneys.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating chronic nephritis proteinuria; in addition, the invention also relates to a preparation method of the traditional Chinese medicine composition. Background technique [0002] According to statistics, the prevalence of chronic kidney disease among people over the age of 18 in urban communities in Shanghai is 11.8%, the prevalence of adults over the age of 40 in Beijing is 9.4%, and the prevalence of adults over the age of 20 in Guangzhou is 10.1%. According to a sample survey, the prevalence rate of chronic renal failure (CKD) in Pudong is as high as 8.94%. The incidence of kidney disease in Shanghai is close to that of the United States, and among kidney patients, the proportion of patients with chronic kidney disease stage 2-3 is the highest. Relevant studies have shown that the incidence and prevalence of end-s...

AI Technical Summary

Problems solved by technology

[0003] It is estimated that the cost of hemodialysis for a patient with renal failure is as high as 40,000 yuan per year, which is expensive, and hemodialysis itself will bring some pain to the patient

At present, the clinical treatment of nephritis albuminuria Tripterygium wilfordii polyglycosides still lacks evidence-based basis, and there is a certain degree of liver damage.